Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Seripharm
Le Mans, Pays de la Loire, Franceseripharm.com ↗
- Ownership
- Private
- Employees
- ~100
- Development stage
- Other
01
Overview
Seripharm is a specialized Contract Development and Manufacturing Organization (CDMO) and API manufacturer focused on high-potency active pharmaceutical ingredients (HPAPIs). The company is recognized as a world leader in the production of taxanes, including paclitaxel, docetaxel, and cabazitaxel, which are essential for various oncology treatments. Operating out of its facility in Le Mans, France, Seripharm offers expertise in plant extraction, hemisynthesis, and chromatography-based purification. Since 2022, the company has been part of the Axplora group (formed by the merger of PharmaZell and Novasep), providing end-to-end support from clinical development to commercial supply.
- Therapeutic areas
- Oncology
- Modalities
- Small molecule
- Industry
- Contract Manufacturing Organization
Beyond the preview
Go deeper on Seripharm.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Seripharm.